News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Image of the Day: Cancer Spheroid
The Scientist Staff | May 15, 2018
3-D balls of cells can be used to screen for potential cancer drugs.
Human Cancer Drugs May Be Effective in Tasmanian Devils
Shawna Williams | Apr 9, 2018
A new study reveals similarities between the transmissible cancers that infect the endangered marsupials, and hints at ways to treat them.
Genetic Screens Provide Clues About Prognosis, Risk of Second Cancer
Shawna Williams | Apr 1, 2018
Mutations in the
gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.
Genetic Risk Factors for Breast Cancer Identified
Ashley P. Taylor | Oct 23, 2017
Researchers identify 72 novel genetic variants associated with breast cancer risk.
First Genetic Screen of Pigs Using ENU
Ashley Yeager | Jul 14, 2017
Using the mutagenic chemical N-ethyl-N-nitrosourea, researchers confirm the role of a gene in a piglet deformity and identify potential models for human diseases.
Companies Pursue Diagnostics that Mine the Microbiome
Andrea Anderson | May 22, 2017
Tests so far typically screen for risky patterns that may augment traditional types of clinical data.
RNAi’s Future in Drug-Target Screening
Catherine Offord | Apr 17, 2017
A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool?
House Bill Could Help Employers Dodge GINA
Joshua A. Krisch | Mar 13, 2017
HR 1313 could circumvent protections offered by the Genetic Information Nondiscrimination Act, enabling employers to incentivize employee sharing of genetic and other medical information.
Targeting the Noncoding Genome with CRISPR
Anna Azvolinsky | Sep 29, 2016
Two independent groups demonstrate the utility of CRISPR-based techniques to identify regulatory elements that govern disease-linked genes.
Targeting Protein Domains with CRISPR
Jenny Rood | May 13, 2015
Researchers use the genome-editing tool to mutate binding pockets and identify potential anti-cancer drug targets.